Recently, an extensive genome-scale in vitro CRISPR/Cas9 screen revealed genes involved in antigen presentation and IFN-signaling to be most relevant to the ability of CD8 T cells to kill melanoma cells (37). The gene discussed is CD8A; the disease is melanoma.